Lynx1 Capital Management LP

CIK

1910456

Location

DORADO, PR

Portfolio Value

Small $382,676,683

Diversification

Moderately concentrated

Filing Date

Global Rank

#2,988 / 7,976 ▲ 505

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+31.4%

Period ended 9 months ago

Filed Nov 14, 2025 · 7mo

16 quarters · since Dec 2021

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+252.7%

SPY

+76.3%

Annualised alpha

+31.4%

Max drawdown

−65.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

13 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025

Top Position

33.2%

+1.5 pts

Top 5

90.5%

+2.2 pts

Top 10

99.5%

−0.3 pts

HHI

2,400

Moderately concentrated+375

Portfolio Trend

16 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$382,676,683	13

Last Quarter's Activity

Export CSV

Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased

3 positions

Ticker	Company	Δ Shares	Shares	Value
GHRS	GH Research PLC	+1,854,238	8,601,189	$122,997,002
CGEM	Cullinan Therapeutics, Inc.	+1,365,248	5,766,090	$34,192,913
DTIL	Precision Biosciences Inc	+6,545	1,042,596	$5,755,129
No positions match the current search.

Trimmed

Positions the filer reduced

3 positions

Ticker	Company	Δ Shares	Shares	Value
ALLO	Allogene Therapeutics, Inc.	−10,510,890	546,119	$677,187
IBIO	iBio, Inc.	−482,676	1,055,897	$876,394
PTGX	Protagonist Therapeutics, Inc	−33,000	700,014	$46,501,930
No positions match the current search.

New Positions

Positions the filer opened this quarter

3 positions

Ticker	Company	Shares	Value
ADCT	ADC Therapeutics SA	1,325,848	$5,303,392
PASG	Passage BIO, Inc.	623,704	$5,008,343
DNLI	Denali Therapeutics Inc.	261,687	$3,799,695
No positions match the current search.

Sold Out

Positions the filer fully exited

3 positions

Ticker	Company	Shares	Value
UPB	Upstream Bio, Inc.	219,247	$2,407,332
NEUP	Neuphoria Therapeutics Inc.	45,806	$325,222
ASMB	Assembly Biosciences, Inc.	10,366	$187,831
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

13 positions · $382,676,683 total · as of Sep 30, 2025

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
STOK	Stoke Therapeutics, Inc. Healthcare	Held	5,404,674	0	$127,009,839	+107.0%	33.19%
GHRS	GH Research PLC Healthcare	Added	8,601,189	+1,854,238	$122,997,002	+49.5%	32.14%
PTGX	Protagonist Therapeutics, Inc Healthcare	Reduced	700,014	-33,000	$46,501,930	+14.8%	12.15%
CGEM	Cullinan Therapeutics, Inc. Healthcare	Added	5,766,090	+1,365,248	$34,192,913	+3.2%	8.94%
CCCC	C4 Therapeutics, Inc. Healthcare	Held	7,098,133	0	$15,757,855	+55.2%	4.12%
TCRX	TScan Therapeutics, Inc. Healthcare	Reduced	7,857,347	-7,857,347	$14,300,371	−37.2%	3.74%
DTIL	Precision Biosciences Inc Healthcare	Added	1,042,596	+6,545	$5,755,129	+32.3%	1.50%
ADCT	ADC Therapeutics SA Healthcare	NEW	1,325,848	NEW	$5,303,392	NEW	1.39%
PASG	Passage BIO, Inc. Healthcare	NEW	623,704	NEW	$5,008,343	NEW	1.31%
DNLI	Denali Therapeutics Inc. Healthcare	NEW	261,687	NEW	$3,799,695	NEW	0.99%
IBIO	iBio, Inc. Healthcare	Reduced	1,055,897	-482,676	$876,394	−25.1%	0.23%
ALLO	Allogene Therapeutics, Inc. Healthcare	Reduced	546,119	-10,510,890	$677,187	−94.6%	0.18%
DSGN	Design Therapeutics, Inc. Healthcare	Held	65,954	0	$496,633	+123.4%	0.13%